|Chapter 2 References|
1. Pasternak CA. A novel form of host defense: membrane protection by calcium and zinc ions. Bioscience Reports. 1987;7:81-91.
2. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold symptoms by zinc gluconate lozenges in a double blind study. Antimicrobial Agents and Chemotheraphy. 1984; 25:20-24.
3. Korant BD, Kaurer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature. 1974; 248:588-590.
4. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. Journal of Virology. 1976;18:298-306.
5. Butterworth BE, Grunert RR, BD Korant, et al. Replication of rhinoviruses. Archives of Virology. 1976;51:169-189.
6. Korant BD, Butterworth BE. Chemical Abstracts. 1976; 85:76, Abs. 85:814y.
7. Korant BD. Role of cellular and viral proteases in the processing of picornavirus proteins. In: Perez-Bercoff R, ed. The Molecular Biology of Picornaviruses. New York:Plenum Publishing; 1979;149-173.
8. Korant BD. Inhibition of viral protein cleavage. In: Gauri KK, ed. Design of Inhibitors of Viral Functions. New York:Academic Press; 1979.
9. Butterworth BE, Korant BD. Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. Journal of Virology. 1974; 14:282-291.
10. Korant BD, Kauer JC, Butterworth BE. Molecular basis of zinc as a viral inhibitor. In: Risby TH, ed. Ultratrace Metal Analysis in Biological Sciences and Environment. Washington D.C.:American Chemical Society; 1979.
11. Prasad AS. Zinc in Human Nutrition. Boca Raton, FL:CRC Press; 1979:67.
12. Merluzzi VJ, Cipriano D, McNeil D, et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Research Communications in Chemical Pathology and Pharmacology. 1989;66: 425-440.
13. Geist FC, Bateman, JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrobial Agents and Chemotherapy. 1987;31: 622-624.
14. Korant BD. E. I. du Pont de Nemours Co., Wilmington, DE. Personal communication, 1992.
15. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Medical Hypotheses. 1985;17: 157-165.
16. Oxford JS, Perrin DD. Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents. Journal of General Virology. 1974;23:59-71.
17. Cload PA, Hutchinson DW. The inhibition of the RNA polymerase activity of influenza virus A by pyrophosphate analogs. Nucleic Acids Research. 1983;11:562l-5628.
18. Vogt VM, Eisenman R, Diggelmann H. Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. Journal of Molecular Biology. 1975;96:471-493.
19. Palan PR, Eidinoff ML. Specific effect of zinc ions on DNA polymerase activity of avian myeloblastosis virus. Molecular and Cellular Biochemistry. 1978;21:67-69.
20. Fuke M. Introduction of specific cleavages into RNAs of RNA bacteriophages for determination of base sequences. Proceedings of the National Academy of Sciences USA. 1974;71:742-745.
21. Black DN, Brown F. Proteins induced by infection with caliciviruses. Journal of General Virology. 1977;38:75-82.
22. Allen GP, O'Callaghan DJ, Randall CC. Purification and characterization of equine herpesvirus-induced DNA Polymerase. Virology. 1977;76:395-408.
23. Gordon YJ, Asher Y, Becker Y. Irreversible inhibition of herpes simplex virus replication in BSC-1 cells by zinc ions. Antimicrobial Agents and Chemotherapy. 1975;8: 377-380.
24. Shlomai J, Asher Y, Gordon YJ, et al. Effect of zinc ions on the synthesis of herpes simplex virus DNA in infected BSC-l cells. Virology. 1975;66:330-335.
25. Fridlender B, Chejanovsky N, Becker Y. Selective inhibition of herpes simplex virus type I DNA polymerase by zinc ions. Virology. 1978;84:551-554.
26. Gupta P, Rapp F. Effect of zinc ions on synthesis of herpes simplex virus type 2-induced polypeptides. Proceedings of the Society for Experimental Biology and Medicine. 1976;152:455-458.
27. Nachtigal M, Nachtigal S. Interactions between human herpesviruses and host cell chromosomes. Archives of Romanian Pathology and Experimental Microbiology. 1978;37:223-249.
28. Nachtigal M, Nachtigal S. Effect of zinc ions, phosphonoacetate, phosphonoformate and violamycin BI on the induction by herpes simplex virus of chromosome abnormalities in cell cultures. Archives of Romanian Path ology and Experimental Microbiology. 1980;39:79-87.
29. Eizuru Y, Hyman RW, Nahhas WA, et al. Herpesvirus RNA in human urogenital tumors. Proceedings of the Society for Experimental Biology and Medicine. 1983; 174:296-301.
30. Falke B, Kahl GF. Ca++, Histidin und Zn++ als faktoren bei ber Riesenzellbildung durch das Herpes-virus hominus. Z Medical Mikrobiology Immunology. 1967; 153:175-189.
31. Ratka M, Lackmann, M, Ueckermann C, et al. Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+. Journal of Virology. 1989;63:3954-3960.
32. Semler BL, Hanecak R, Dorner LF, et al. Poliovirus RNA synthesis in vitro: structural elements and antibody inhibition. Virology. 1983;126:624-635.
33. Lawrence C, Thach RE. Identification of a viral protein involved in post-translational maturation of the encephalomyocarditis virus capsid precursor. Journal of Virology. 1975;15:918-928.
34. Gainer JH. Antiviral activity of zinc sulfate and zinc sulfate + poly I / poly C on EMCV mortality. In: Program and Abstracts of the 14th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco:American Society for Microbiology. 1974; abstract no. 234.
35. Esposito JJ, Obijeski JF. Enterovirus type 70 viron and intracellular proteins. Journal of Virology. 1976;18:1160-1162.
36. Polatnick J, Bachrach HL. Effect of zinc and other chemical agents on foot-and-mouth disease virus replication. Antimicrobial Agents and Chemotherapy. 1978;13: 731-734.
37. Sangar DV, Bryant J, Harris TJ, et al. Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate. Journal of Virology. 1981;39: 67-74.
38. Firpo EJ, Palma EL. Inhibition of foot-and-mouth disease virus and procapsid synthesis by zinc ions. Archives of Virology. 1979;61:175-181.
39. Nakai K, Lucas-Lenard J. Processing of mengovirus precursor polypeptides in the presence of zinc ions and sulfhydryl compounds. Journal of Virology. 1976;18:918-925.
40. Levinson W, Faras A, Woodson B, et al. Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations. Proceedings of the National Academy of Sciences, USA. 1973;70:164-168.
41. Clegg JCS, Brzeski H, Kennedy SIT. RNA polymerase components in Semliki Forest virus-infected cells: synthesis from large precursors. Journal General Virology. 1976;32:413-430.
42. Bracha M, Schlesinger MJ. Inhibition of Sindbis virus replication by zinc ions. Virology. 1976;72: 272-277.
43. Epstein J. SV40-transformed human cells fail to grow in zinc concentrations which permit normal human fibroblast proliferation. Journal of Cellular Physiology. 1982; 110:17-22.
44. Huff JW, Sastry KS, Gordon MP, et al. The action of metal ions on tobacco mosaic virus ribonucleic acid. Biochemistry. 1964;3:501-506.
45. Katz E, Margalith E. Inhibition of vaccinia virus maturation by zinc chloride. Antimicrobial Agents and Chemotherapy. 1981;19:213-217.
46. Zaslavsky V. Inhibition of vaccinia virus growth by zinc ions: effect on early RNA and thymidine kinase synthesis. Journal of Virology. 1979;29: 405-408.
47. Diener TO, McKinley MP, Prusiner SB. Viroids and prions. Proceedings of the National Academy of Sciences USA. 1982;79:5220-5224.
48. Butzow JL, Eichhorn GL. Different susceptibility of DNA and RNA to cleavage by metal ions. Nature. 1975;254: 358-359.
49. Zhang ZY, Reardon IM, Hui JO, et al. Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. Biochemistry. 1991;30: 8717-8721.
50. Sergio W. Zinc salts that may be effective against the AIDS Virus HIV. Medical Hypotheses. 1988; 26:251-253.
51. Korant BD. Strategies to inhibit viral polyprotein cleavages. In: St. Georgiev V, McGowan JJ, eds. AIDS: Anti-HIV Agents, Therapies, and Vaccines. Annals of the New York Academy of Sciences. 1990;616:252-257.
52. South, TL, Blake PR, Sowder RC III, et al. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry. 1990;29:7786-7789.
53. Gallagher IHC, Cutress TW. The effect of trace elements on the growth and fermentation by oral Streptococci and Actinomyces. Archives of Oral Biology. 1977;22:555-562.
54. Skjörland K, Gjermo P, Rölla G. Effect of some polyvalent cations on plaque formation in vivo. Scandinavian Journal of Dental Research. 1978; 86:103-107.
55. Oppermann RV, Rölla G, Johansen JR, et al. Thiol groups and reduced acidogenicity of dental plaque in the presence of metal ions in vivo. Scandinavian Journal of Dental Research. 1980;88:389-396.
56. Oppermann RV, Rölla G. Effect of some polyvalent cations on the acidogenicity of dental plaque in vivo. Caries Research. 1980;14:422-427.
57. Greenberg SB, Harris D, Giles P, et al. Inhibition of Chlamydia trachomatis growth in McCoy, HeLa, and human prostate cells by zinc. Antimicrobial Agents and Chemotherapy. 1985;27:953-957.
58. Schlievert P, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. VI. Evidence for a zinc-peptide antibacterial system. American Journal of Obstetrics and Gynecology. 1976;125: 906-910.
59. Windholz M, Budavari S, Blumetti RF, et al, eds. The Merck Index. Rahway NJ:Merck & Company. 1983;1455-1458.
60. Ibid; 226.
61. Ibid; 1153.
62. Osol A. Astringents and antiperspirants. In: Osol A. ed. Remington's Pharmaceutical Sciences, 16th Edition. Easton:Mack Publishing Co. 1980;720-723.
63. Sugarman B. Zinc and infection. Reviews of Infectious Diseases. 1983;5:137-147.
64. Bashford CL, Alder GM, Menestrina G, et al. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents - a common mechanism blocked by divalent cations. The Journal of Biological Chemistry. 1986;261: 9300-9308.
65. Bashford CL, Menestrina G, Henkart PA, et al. Cell membrane damage by cytolysin. The Journal of Immunology. 1988;141:3965-3974.
66. Bashford CL, Alder GM, Graham JM, et al. Ion modulation of membrane permeability: Effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. Journal of Membrane Biology. 1988;103:79-94.
67. Pasternak CA. Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+. Bio Essays. 1987; 6:14-19.
68. Lichtenheld MC, Olsen KJ, Lu P, et al. Structure and function of human perforin. Nature. 1988; 335:448-451.
69. Boyle MDP, Langone JJ, Borsos T. Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts. The Journal of Immunology. 1979; 122:1209-1213.
70. Prasad AS. Zinc in humans. In: Risby TH, ed. Ultratrace Metal Analysis in Biological Sciences and Environment. Washington D.C.:American Chemical Society; 1979.
71. Barrett JT. Textbook of Immunology. St. Louis:C. V. Mosby Co; 1978.
72. Struckhoff G, Heymann E. Rat peritoneal mast cells release dipeptidyl peptidase II. Biochemistry Journal. 1986;236:215-219.
73. Danscher G, Obel J, Thorlacius-Ussing O. Electron microscopic demonstration of metals in rat mast cells. A cytochemical study based on an improved sulfide silver method. Histochemistry. 1980;66: 293-300.
74. Selye H. The Mast Cell. Washington DC: Butterworths Press; 1965;302.
75. Uvnas B, Aborg CH, Bergqvist U. No role for zinc in the storage of histamine in rat peritoneal mast cells. Acta Physiologica Scandinavica. 1975;93:401-408.
76. Marone G, Lichtenstein LM. Inhibition of histamine release from human basophils by zinc chloride. Federation Proceedings. 1978;37:590.
77. Marone G, Findlay SR, Lichtenstein LM. Modulation of basophil histamine release by zinc. Journal of Allergy and Clinical Immunology. 1979;65:171.
78. Marone G, Columbo M, de Paulis A, et al. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents and Action. 1986;18:103-106.
79. Chvapil M. Effect of zinc on cells and biomembranes. Medical Clinics of North America. 1976; 60:799-812.
80. Mousli M, Gies J-P, Bertrand G. The Sensitivity to Zn2+ discriminates between typical and atypical mast cells. Agents and Actions. 1990;30:102-105.
81. Martell AE, Smith RM. Critical Stability Constants. New York: Plenum Press; 1991.
82. Berthon G, Kayali A. Histamine as a ligand in blood plasma. Part 5. Computer simulated distribution of metal histamine complexes in normal blood plasma and discussion of the implications of a possible role of zinc and copper in histamine catabolism. Agents and Actions. 1982;12:398-407.
83. Berthon G, Varsamidis A, Blaquiere C, et al. Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand coordination. In vitro tests on lymphocyte proliferation. Agents and Actions. 1987;22:231-247.
84. Berthon G, Germonneau P. Histamine as a ligand in blood plasma. Part 6. Aspartate and glutamate as possible partner ligands for zinc and histamine to favor histamine catabolism. Agents and Actions. 1982;12:619-629.
85. Part II, Formulas. In: Merck's 1901 Manual of the Materia Medica. New York:Merck and Co. 1901;125.
86. Remedies for nasal catarrh. In: Merck's Manual of the Materia Medica. New York:Merck and Co. 1923;160.
87. Franklin P. Treatment of hay fever by intranasal zinc ionization. The British Medical Journal. June 27, 1931; 1115-1116.
88. Shields C. The ionization treatment of hay fever. The Practitioner. January-June 1936;645-648.
89. Bailey LD, Shields C. Treatment of hay fever by intranasal zinc ionization. The British Medical Journal. April 17, 1937;808.
90. Zinc borate decongestant. In: Howard MA, ed. Modern Drug Encyclopedia and Therapeutic Index. New York:Drug Publications; 1956;1168.
91. Weir CD. Intranasal ionization in the treatment of vasomotor nasal disorders. The Journal of Laryngology and Otology. 1967;81:1143-1149.
92. Castleman M. Cold Cures. New York:Fawcett Columbine;1987.
93. Eggleston PA, Hendley JO, Gwaltney JM Jr, et al. Histamine in Nasal Secretions. International Archives of Allergy and Applied Immunology. 1978; 57:193-200.
94. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. Journal of Infectious Diseases. 1988; 157:133-142.
95. Eggleston PA, Hendley JO, Gwaltney JM Jr. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinoviral infection. Acta Oto-Laryngologia Supplement. 1984; 413:25-35.
96. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. Journal of Infectious Diseases. 1990;161:120-123.
97. Gaffey MJ, Gwaltney JM Jr, Sastre A, et al. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds. American Review of Respiratory Disease. 1987;136: 556-560.
98. Gaffey MJ, Kaiser DL, Hayden FG. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatric Infectious Disease Journal. 1988;7:223-228.
99. Naclerio RM, Proud D, Kagey-Sobotka A, et al. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatric Infectious Disease Journal. 1988;7:218-222.
100. Borum P, Gronborg H, Brofeldt S, et al. Nasal reactivity in rhinitis. European Journal of Respiratory Diseases Supplement. 1983;128 (Pt 1):65-71.
101. Carter-Barnett JK, Cruse LW, Proud D. Kinins are generated in nasal secretions during influenza A infections in ferrets. American Review of Respiratory Diseases. 1990;142:162-166.
102. Lemanske RF Jr, Dick EC, Swensen CA, et al. Rhinovirus upper respiratory infection increases airway hyper reactivity and late asthmatic reactions. Journal of Clinical Investigation. 1989;83:1-10.
103. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. New England Journal of Medicine. 1981;305:841-846.
104. Prasad AS. Zinc in Human Nutrition. Boca Raton, FL: CRC Press; 1979;65.
105. Chandra RK, Au B. Single nutrient deficiency and cell-mediated immune responses: Zinc. The American Journal of Clinical Nutrition. 1980;33:736-738.
106. Prasad AS. Discovery and importance of zinc in human nutrition. Federation Proceedings. 1984; 43:2829-2834.
107. Beisel WR, Edelman R, Nauss K, et al. Single-nutrient effects on immunologic functions. Journal of the American Medical Association. 1981;245: 53-58.
108. Phillips JL, Azari P. Zinc transferrin: Enhancement of nucleic acid in phytohemagglutinin-stimulated human lymphocytes. Cellular Immunology. 1974;10:31-37.
109. Dardenne M, Pléau JM, Nabarra B, et al. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proceedings of the National Academy of Sciences USA. 1982;79: 5370-5373.
110. Bates J, McClain CJ. The effect of severe zinc deficiency on serum levels of albumin, transferrin, and prealbumin in man. American Journal of Clinical Nutrition. 1981;4: 1655-1660.
111. Beach RS, Gershwin ME, Hurley LS. Gestational zinc deprivation in mice: persistence of immunodeficiency for three generations. Science. 1982;218 469-471.
112. Golden MHN, Jackson AA, Golden BE. Effect of zinc on thymus of recently malnourished children. Lancet. November 19, 1977;1057-1059.
113. Duchateau J, Delepesse G, Vrijens R, et al. Beneficial effects of oral zinc supplementation on the immune response of old people. The American Journal of Medicine. 1981;70:1001-1004.
114. Duchateau J, Delespesse G, Vereecke P. Influence of oral zinc supplementation on the lymphocyte response tomitogens of normal subjects. The American Journal of Clinical Nutrition. 1981;34:88-93.
115. Mathe G, Blazsek I, Gil-Delgado MA, et al. The effect of zinc on normal and neoplastic T-lymphocyte proliferation. Medical Oncology & Tumor Pharmacotherapy. 1985;2: 203-210.
116. Wazewska-Czyzewska M, Wesierska-Gadek J, Legutko L. Immunostimulatory effects of zinc in patients with acute lymphoblastic leukemia. Folia Haematology. 1978;105: 727-732.
117. Cavdar AO, Babacan E, Gözdasoglu S, et al. Zinc and anergy in pediatric Hodgkin's disease in Turkey. Cancer. 1987;59:305-309.
118. Rocklin RE, Haberek-Davidson A. Histamine activates suppressor cells in vitro using a coculture technique. Journal of Clinical Immunology. 1981; 1:73-79.
119. Chandra RK. Excessive intake of zinc impairs immune responses. Journal of the American Medical Association. 1984;252:1443-1446.
120. Reardon CL, Lucas DO. Zn++ - and Hg++ - mediated induction of mitogenesis, cell-mediated cytotoxicity, and interferon production in murine lymphocytes. In: Parker JW, O'Brian RL, eds. Proceedings of the Fifteenth Leukocyte Culture Conference. New York:John Wiley and Sons, Inc. 1983; 449.
121. Reardon CL, Lucas DO. Heavy metal mitogenesis: Zn++ and Hg++ induce cellular cytotoxicity and interferon production in murine T lymphocytes. Immunobiology. 1987; 175:455-469.
122. Salas M, Kirchner H. Induction of interferon-g in human leukocyte cultures stimulated by Zn2+. Clinical Immunology and Immunopathology. 1987;45:139-142.
123. Gainer JH. Effects on interferon of heavy metal excess and zinc deficiency. American Journal of Veterinary Research. 1977;38:863-867.
124. Norris D. Zinc and cutaneous inflammation. Archives of Dermatology. 1985;121:985-989.
125. Chvapil M, Stankova L, Weldy P, et al. The role of zinc in the function of some inflammatory cells. In: Zinc Metabolism: Current Aspects in Health and Disease. New York: Alan R. Liss, Inc; 1977;103-122.
126. Subcommittee on Zinc, Committee on Medical and Biological Effects of Environmental Pollutants, Division of Medical Sciences, Assembly of Life Sciences National Research Council. Zinc. Baltimore:University Park Press; 1979; 235.
127. Beisel WR, Pekarek RS, Wannemaker RW Jr. Homeostatic mechanisms affecting plasma zinc levels in acute stress. In: Prasad AS, Oberleas D eds. Trace Elements in Human Health and Disease. New York:Academic Press; 1976;97.
128. Martinez-Cairo S, Coello P, Alvarez T, et al. PMN cell phagocytic function in malnourished patients with zinc uptake. Archivos de Investigation Medica. 1980;11:227-238.
129. Kelley RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biology of Reproduction. 1983;28:883-889.
130. Cohen S, Tyrrell DAJ, Smith AP. Psychological stress and susceptibility to the common cold. New England Journal of Medicine. 1991;325:606-612.